Literature DB >> 2047874

Monoclonal antibodies in diagnosis and therapy.

T A Waldmann1.   

Abstract

Monoclonal antibodies have been applied clinically to the diagnosis and therapy of an array of human disorders, including cancer and infectious diseases, and have been used for the modulation of immune responses. Effective therapy using unmodified monoclonal antibodies has, however, been elusive. Recently, monoclonal antibody-mediated therapy has been revolutionized by advances such as the definition of cell-surface structures on abnormal cells as targets for effective monoclonal antibody action, genetic engineering to create less immunogenic and more effective monoclonal antibodies, and the arming of such antibodies with toxins or radionuclides to enhance their effector function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047874     DOI: 10.1126/science.2047874

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  43 in total

1.  A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope.

Authors:  C L Chirinos-Rojas; M W Steward; C D Partidos
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

Review 2.  Back to the future: antibody-based strategies for the treatment of infectious diseases.

Authors:  H Barbaros Oral; Cüneyt Ozakin; Cezmi A Akdiş
Journal:  Mol Biotechnol       Date:  2002-07       Impact factor: 2.695

3.  In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells.

Authors:  M J Embleton; G Gorochov; P T Jones; G Winter
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.

Authors:  Z Z Su; J Lin; R Shen; P E Fisher; N I Goldstein; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

5.  The human antibody library.

Authors:  S J Russell; M B Llewelyn; R E Hawkins
Journal:  BMJ       Date:  1992-03-07

6.  Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agent.

Authors:  Hua Xiong; Ling Li; Qin-Chuan Liang; Hui-Jie Bian; Juan Tang; Qin Zhang; Li Mi; Zhi-Nan Chen
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

7.  Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

Authors:  Yun-Feng Yao; Zhi Yang; Zhen-Fu Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

8.  Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets.

Authors:  Matthew H Bakalar; Aaron M Joffe; Eva M Schmid; Sungmin Son; Marija Podolski; Daniel A Fletcher
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

9.  Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.

Authors:  R O Williams; J Ghrayeb; M Feldmann; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; R P Baum; M Tauber; W Boeckmann; S Weier; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.